- $45.51bn
- $37.56bn
- $6.85bn
- 72
- 15
- 60
- 47
REG - Stock Exch Notice - Admission to Trading - 21/06/2023
AnnouncementREG - Leverage Shares PLC Leverage3XLongMrna$ Leverage3XLongMrna£ Leverage3XLongMrnaE - ETP Securityholder Meeting 3x Long Moderna
AnnouncementREG - Leverage Shares PLC Leverage3XLongMrna$ Leverage3XLongMrna£ Leverage3XLongMrnaE - ETP Securityholder meeting 3x Long Moderna (MRNA)
AnnouncementREG - Stock Exch Notice - Admission to Trading - 02/05/2023
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 25/04/2023
AnnouncementRCS - Moderna Inc - MRNA Cancer Vaccine Update
AnnouncementRCS - Moderna Inc - Moderna Finalizes Agreement with Kenyan Government
AnnouncementRCS - Moderna Inc - Chantal Friebertshäuser Joins Moderna
AnnouncementRCS - Moderna Inc - EMA Committee for Medicinal Products for Human Use
AnnouncementRCS - Moderna Inc - Moderna and Merck Announce mRNA Cancer Vaccine
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 28/10/2022
AnnouncementRCS - Moderna Inc - EMA Recommends Authorization of Moderna Vaccine
AnnouncementRCS - Moderna Inc - EMA Issues Positive Opinion
AnnouncementRCS - Moderna Inc - Merck and Moderna Announce Exercise of Option
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 06/10/2022
AnnouncementRCS - BB Biotech AG - Edison issues review on BB Biotech (BION)
Announcement